HHM Wealth Advisors’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-300
Closed -$3.89K 880
2025
Q1
$3.89K Hold
300
﹤0.01% 693
2024
Q4
$3.83K Hold
300
﹤0.01% 699
2024
Q3
$3.34K Hold
300
﹤0.01% 687
2024
Q2
$3.37K Hold
300
﹤0.01% 670
2024
Q1
$3.72K Hold
300
﹤0.01% 647
2023
Q4
$4.19K Hold
300
﹤0.01% 640
2023
Q3
$4.43K Hold
300
﹤0.01% 645
2023
Q2
$3.88K Hold
300
﹤0.01% 685
2023
Q1
$2.94K Hold
300
﹤0.01% 699
2022
Q4
$3.19K Hold
300
﹤0.01% 568
2022
Q3
$3K Hold
300
﹤0.01% 572
2022
Q2
$4K Hold
300
﹤0.01% 665
2022
Q1
$3K Hold
300
﹤0.01% 649
2021
Q4
$4K Hold
300
﹤0.01% 589
2021
Q3
$6K Hold
300
﹤0.01% 531
2021
Q2
$3K Hold
300
﹤0.01% 558
2021
Q1
$3K Hold
300
﹤0.01% 519
2020
Q4
$1K Hold
300
﹤0.01% 507
2020
Q3
$1K Hold
300
﹤0.01% 482
2020
Q2
$3K Hold
300
﹤0.01% 434
2020
Q1
$1K Buy
+300
New +$1.39K ﹤0.01% 451

Other funds holding DVAX

HHM Wealth Advisors's DVAX Position: Q2 2025 in Review

HHM Wealth Advisors sold out of Dynavax Technologies (DVAX) in Q2 2025, closing a stake of 300 shares — an estimated $3.89K sold.

HHM Wealth Advisors first reported a position in DVAX in Q1 2020 and held it in 21 quarters. The position peaked at $6K in Q3 2021. 268 funds tracked by Wall St. Rank hold DVAX as of Q2 2025.

  • HHM Wealth Advisors reported no remaining Dynavax Technologies position as of Q2 2025 after selling out during the quarter.
  • HHM Wealth Advisors sold 300 Dynavax Technologies shares in Q2 2025, an estimated $3.89K.
  • HHM Wealth Advisors first reported a position in Dynavax Technologies in Q1 2020 and held it in 21 quarters.
  • HHM Wealth Advisors's Dynavax Technologies position peaked at $6K in Q3 2021.
  • 268 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2025.

Based on HHM Wealth Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.